The global bone void fillers market size was estimated to be USD 4.68 billion in 2023 and is expected to reach at USD 10.2 billion by 2033 with a CAGR of 7.32% during the forecast period 2023-2033. Increasing prevalence of orthopaedic diseases such as osteoporosis, osteoarthritis, bone tumor, scoliosis, & bone infection, rising research & development activities in bone void fillers industry, growing investment by private & government organizations, surge in number of geriatric populations, increasing orthopaedic surgeries such as cervical & lumbar spine surgery procedure, rising hip & knee replacements, and surge in product launch of bone void fillers are some of the key factors boosting the market growth.
Surge in product launch of bone void fillers is predicted to boost the market growth during the forecast period. For instance, in February 2022, Orthofix Medical Inc., a manufacturer of medical equipment for orthopaedic and spine solutions, has introduced Opus BA, a synthetic bioactive bone graft designed for cervical and lumbar spine surgery procedures.
By Type, Demineralized bone matrix was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to rising use for dental implants in orthopaedic surgery and increasing technological advancements, and surge in introduction of new products. Additionally, Calcium phosphate bone graft substitute is predicted to grow at fastest CAGR during the forecast period owing to growing use of synthetic substitute such as polymer & ceramic in treatment of bone defects and rising focus on expansion by major market players. For instance, in July 2022, curasan AG, a renowned global supplier of biomaterials for bone and tissue regeneration in dental and orthobiologic applications, expands its range of products with CERASORB® CPC (Calcium Phosphate Cement) Bone Void Fillers, catering to maxillofacial, orthopedic, and trauma surgical procedures.
By Form, Putty was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to growing prevalence of bone diseases, surge in number of non-invasive & minimally invasive surgeries, and rising launch of new products by major market players. Additionally, Paste is predicted to grow at fastest CAGR during the forecast period owing to growing number of orthopaedic surgeries which use substance to fill bone voids in the form of paste and rising research & development activities to enhance the benefits of paste fillers. For instance, in February 2020, Clinical studies were started by BBS-Bioactive Bone Substitutes at facilities in Poland and Finland. The study utilized ARTEBONE paste as a bone void filler for infusion in ankle and subtalar joints. The paste form demonstrated no safety issues or complications related to the product. Furthermore, it minimized the established risks and morbidity associated with synthetic bone growth factor products.
By Application, Bone fracture was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to the rising prevalence of osteoporosis, growing geriatric population, increasing cases of sport & accident injuries, and surge in launch of new products. For instance, in January 2022, Synergy Biomedical, LLC introduced BIOSPHERE FLEX SP EXTREMITIS, a synthetic bioactive bone graft. This product comprises a sheet putty made from novel spherical bioactive glass granules, mixed with a porous carrier of either collagen or sodium hyaluronate. Additionally, Spinal fusion segment is predicted to grow at fastest CAGR during the forecast period owing to rising number of spine injury and growing number of spinal fusion procedure.
By End-user, Hospital was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to the growing initiatives for the development of healthcare infrastructure by government, surge in number of hospitals & clinics, rising number of orthopaedic procedures being conducted in hospital facilities, and increasing collaborations within market players. For instance, in January 2022, BONESUPPORT AB and OrthoPediatrics Corp. have entered into a distribution agreement to provide CERAMENT BONE VOID FILLER to pediatric hospitals across the United States. Additionally, Specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to increasing awareness regarding specialty clinics and growing adoption of fillers across specialty clinics.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of synthetic bone void fillers, rising presence of bone void fillers manufacturing industry, growing well-developed healthcare infrastructure, surge in number of patients suffering from bone disease, increasing launch of advanced products. For instance, in January 2022, Bone Solutions Inc. introduced Mg OSTEOINJECT, a bone void filler, in the United States. This product incorporates magnesium, an essential element for bone health and growth. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of orthopaedic diseases, growing awareness regarding the use of bone void fillers, increasing healthcare expenditure, surge in geriatric population, and rising launch of advanced products. For instance, in September 2021, Orthofix Medical Inc. has unveiled the Opus Mg Set, a synthetic bone void filler that contains magnesium. This innovative product is designed for orthopaedic procedures and offers a specialized solution for fracture care and trauma applications by filling non-structural bony voids or gaps during surgery.
Surge in product launch of bone void fillers is predicted to boost the market growth during the forecast period. For instance, in February 2022, Orthofix Medical Inc., a manufacturer of medical equipment for orthopaedic and spine solutions, has introduced Opus BA, a synthetic bioactive bone graft designed for cervical and lumbar spine surgery procedures.
By Type, Demineralized bone matrix was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to rising use for dental implants in orthopaedic surgery and increasing technological advancements, and surge in introduction of new products. Additionally, Calcium phosphate bone graft substitute is predicted to grow at fastest CAGR during the forecast period owing to growing use of synthetic substitute such as polymer & ceramic in treatment of bone defects and rising focus on expansion by major market players. For instance, in July 2022, curasan AG, a renowned global supplier of biomaterials for bone and tissue regeneration in dental and orthobiologic applications, expands its range of products with CERASORB® CPC (Calcium Phosphate Cement) Bone Void Fillers, catering to maxillofacial, orthopedic, and trauma surgical procedures.
By Form, Putty was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to growing prevalence of bone diseases, surge in number of non-invasive & minimally invasive surgeries, and rising launch of new products by major market players. Additionally, Paste is predicted to grow at fastest CAGR during the forecast period owing to growing number of orthopaedic surgeries which use substance to fill bone voids in the form of paste and rising research & development activities to enhance the benefits of paste fillers. For instance, in February 2020, Clinical studies were started by BBS-Bioactive Bone Substitutes at facilities in Poland and Finland. The study utilized ARTEBONE paste as a bone void filler for infusion in ankle and subtalar joints. The paste form demonstrated no safety issues or complications related to the product. Furthermore, it minimized the established risks and morbidity associated with synthetic bone growth factor products.
By Application, Bone fracture was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to the rising prevalence of osteoporosis, growing geriatric population, increasing cases of sport & accident injuries, and surge in launch of new products. For instance, in January 2022, Synergy Biomedical, LLC introduced BIOSPHERE FLEX SP EXTREMITIS, a synthetic bioactive bone graft. This product comprises a sheet putty made from novel spherical bioactive glass granules, mixed with a porous carrier of either collagen or sodium hyaluronate. Additionally, Spinal fusion segment is predicted to grow at fastest CAGR during the forecast period owing to rising number of spine injury and growing number of spinal fusion procedure.
By End-user, Hospital was the highest revenue-grossing segment in the global bone void fillers market in 2022 owing to the growing initiatives for the development of healthcare infrastructure by government, surge in number of hospitals & clinics, rising number of orthopaedic procedures being conducted in hospital facilities, and increasing collaborations within market players. For instance, in January 2022, BONESUPPORT AB and OrthoPediatrics Corp. have entered into a distribution agreement to provide CERAMENT BONE VOID FILLER to pediatric hospitals across the United States. Additionally, Specialty clinics is predicted to grow at fastest CAGR during the forecast period owing to increasing awareness regarding specialty clinics and growing adoption of fillers across specialty clinics.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of synthetic bone void fillers, rising presence of bone void fillers manufacturing industry, growing well-developed healthcare infrastructure, surge in number of patients suffering from bone disease, increasing launch of advanced products. For instance, in January 2022, Bone Solutions Inc. introduced Mg OSTEOINJECT, a bone void filler, in the United States. This product incorporates magnesium, an essential element for bone health and growth. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of orthopaedic diseases, growing awareness regarding the use of bone void fillers, increasing healthcare expenditure, surge in geriatric population, and rising launch of advanced products. For instance, in September 2021, Orthofix Medical Inc. has unveiled the Opus Mg Set, a synthetic bone void filler that contains magnesium. This innovative product is designed for orthopaedic procedures and offers a specialized solution for fracture care and trauma applications by filling non-structural bony voids or gaps during surgery.
Segmentation: Bone Void Fillers Market Report 2022 - 2033
Bone Void Fillers Market Analysis & Forecast by Type 2022 - 2033 (Revenue USD Bn)
- Calcium Phosphate Bone Graft Substitute
- Collagen Matrix
- Demineralized Bone Matrix
- Others
Bone Void Fillers Market Analysis & Forecast by Form 2022 - 2033 (Revenue USD Bn)
- Granules
- Gel
- Putty
- Paste
- Others
Bone Void Fillers Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Bone Fracture
- Spine Fusion
- Others
Bone Void Fillers Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Hospital
- Specialty Clinics
- Others
Bone Void Fillers Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Bone Void Fillers Market: Type Estimates & Trend Analysis
8. Bone Void Fillers Market: Form Estimates & Trend Analysis
9. Bone Void Fillers Market: Application Estimates & Trend Analysis
10. Bone Void Fillers Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Bone Void Fillers Market
13. Europe Global Bone Void Fillers Market
14. Asia Pacific Global Bone Void Fillers Market
15. Latin America Global Bone Void Fillers Market
16. MEA Global Bone Void Fillers Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Baxter International Inc.
- Medtronic plc
- Stryker Corporation
- NuVasive Inc
- Arthrex Inc
- Smith and Nephew plc
- Wright Medical Group Inc
- Orthofix Medical Inc
- Zimmer Biomet
- Depuy Synthes Companies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 4.48 Billion |
| Forecasted Market Value ( USD | $ 10.2 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
